Low levels of 25-hydroxyvitamin D in the pediatric populations: Prevalence and clinical outcomes

Pediatric Health

Volumn 4, Issue 1, 2010, Pages 89-97

  Melamed, Michal L ^a   Kumar, Juhi ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Asthma; Bone mass; Diabetes mellitus; Hypertension; Rickets; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; COLECALCIFEROL; HEMOGLOBIN A1C; PARATHYROID HORMONE; PLACEBO; VITAMIN D;

ASTHMA; BONE DENSITY; CHILD; CHILD GROWTH; CHILD NUTRITION; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREVALENCE; PRIMARY OSTEOPOROSIS; REVIEW; RICKETS; RISK FACTOR; RISK REDUCTION; SECONDARY OSTEOPOROSIS; TREATMENT OUTCOME; UNITED STATES; URINARY TRACT INFECTION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 77951677147     PISSN: 17455111     EISSN: None     Source Type: Journal    
DOI: 10.2217/phe.09.72     Document Type: Review

References (102)

1. Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 80(6 Suppl.), 1678S-1688S (2004).
2. Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr. 69(5), 842-856 (1999).
3. Parftt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD: Vitamin D and bone health in the elderly. Am. J. Clin. Nutr. 36(5 Suppl.), 1014-1031 (1982).
4. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D: Am J Physiol Renal Physiol. 289(1), F8-28 (2005).
5. Hewison M, Burke F, Evans KN et al.: Extra-renal 25-hydroxyvitamin D3-1a-hydroxylase in human health and disease. J. Steroid Biochem. Mol. Biol. 103(3-5), 316-321 (2007).
6. O'Connell TD, Simpson RU: Immunochemical identifcation of the 1,25-dihydroxyvitamin D3 receptor protein in human heart. Cell. Biol. Int. 20(9), 621-624 (1996).
7. Sandgren ME, Bronnegard M, DeLuca HF: Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat. Biochem. Biophys. Res. Commun. 181(2), 611-616 (1991).
8. Bischoff HA, Borchers M, Gudat F et al.: In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem. J. 33(1), 19-24 (2001).
9. Brown J, Bianco JI, McGrath J J, Eyles DW: 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett. 343(2), 139-143 (2003).
10. Smotkin-Tangorra M, Purushothaman R, Gupta A, Nejati G, Anhalt H, Ten S: Prevalence of vitamin D insuffciency in obese children and adolescents. J. Pediatr. Endocrinol. Metab. 20(7), 817-823 (2007).
11. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D defciency among healthy adolescents. Arch. Pediatr. Adolesc. Med. 158(6), 531-537 (2004).
12. Lee JM, Smith JR, Philipp BL, Chen TC, Mathieu J, Holick MF: Vitamin D defciency in a healthy group of mothers and newborn infants. Clin. Pediatr. (Phila). 46(1), 42-44 (2007).
13. Gordon CM, Feldman HA, Sinclair L et al.: Prevalence of vitamin D defciency among healthy infants and toddlers. Arch. Pediatr. Adolesc. Med. 162(6), 505-512 (2008).
14. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA: Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am. J. Clin. Nutr. 88(6), 1519-1527 (2008).
15. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML: Prevalence and associations of 25-hydroxyvitamin D defciency in US children: NHANES 2001-2004. Pediatrics (2009).
16. Harinarayan CV, Ramalakshmi T, Prasad U V, Sudhakar D: Vitamin D status in Andhra Pradesh: a population based study. Indian J. Med. Res. 127(3), 211-218 (2008).
17. Madar AA, Stene LC, Meyer HE: Vitamin D status among immigrant mothers from Pakistan, Turkey and Somalia and their infants attending child health clinics in Norway. Br. J. Nutr. 101(7), 1052-1058 (2009).
18. Gharaibeh MA, Stoecker BJ: Assessment of serum 25(OH)D concentration in women of childbearing age and their preschool children in Northern Jordan during summer. Eur. J. Clin. Nutr. 63(11), 1320-1326 (2009).
19. Lebrun JB, Moffatt ME, Mundy RJ et al.: Vitamin D defciency in a Manitoba community. Can. J. Public Health 84(6), 394-396 (1993).
20. Duran P, Mangialavori G, Biglieri A, Kogan L, Abeya Gilardon E: Nutrition status in Argentinean children 6 to 72 months old: results from the National Nutrition and Health Survey (ENNyS). Arch. Argent Pediatr. 107(5), 397-404 (2009).
21. Whiting SJ, Calvo MS: Dietary recommendations for vitamin D: a critical need for functional end points to establish an estimated average requirement. J. Nutr. 135(2), 304-309 (2005).
22. Bowden SA, Robinson RF, Carr R, Mahan JD: Prevalence of vitamin D defciency and insuffciency in children with osteopenia or osteoporosis referred to a pediatric metabolic bone clinic. Pediatrics 121(6), e1585-1590 (2008).
23. Cheng S, Tylavsky F, Kroger H et al.: Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. Am. J. Clin. Nutr. 78(3), 485-492 (2003).
24. Outila TA, Karkkainen MU, Lamberg-Allardt CJ. Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density. Am. J. Clin. Nutr. 74(2), 206-210 (2001).
25. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M: Vitamin D defciency in children and its management: review of current knowledge and recommendations. Pediatrics 122(2), 398-417 (2008).
26. Nesby-O'Dell S, Scanlon KS, Cogswell ME et al.: Hypovitaminosis D prevalence and determinants among African-American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Clin. Nutr. 76(1), 187-192 (2002).
27. Thomas MK, Lloyd-Jones DM, Thadhani RI et al.: Hypovitaminosis D in medical inpatients. N. Engl. J. Med. 338(12), 777-783 (1998).
28. Sahu M, Bhatia V, Aggarwal A et al.: Vitamin D defciency in rural girls and pregnant women despite abundant sunshine in northern India. Clin. Endocrinol. (Oxf). (2008).
29. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 84(1), 18-28 (2006).
30. Matsuo K, Mukai T, Suzuki S, Fujieda K: Prevalence and risk factors of vitamin D defciency rickets in Hokkaido, Japan. Pediatr Int. 51(4), 559-562 (2009).
31. Pappa HM, Gordon CM, Saslowsky TM et al.: Vitamin D status in children and young adults with infammatory bowel disease. Pediatrics 118(5), 1950-1961 (2006).
32. Grey V, Atkinson S, Drury D et al.: Prevalence of low bone mass and defciencies of vitamins D and K in pediatric patients with cystic fbrosis from 3 Canadian centers. Pediatrics 122(5), 1014-1020 (2008).
33. Ali FN, Arguelles LM, Langman CB, Price HE: Vitamin D defciency in children with chronic kidney disease: uncovering an epidemic. Pediatrics 123(3), 791-796 (2009).
34. Gessner BD, de Schweinitz E, Petersen KM, Lewandowski C: Nutritional rickets among breast-fed black and Alaska Native children. Alaska Med. 39(3), 72-74, 87 (1997).
35. McAllister JC, Lane AT, Buckingham BA: Vitamin D defciency in the San Francisco Bay Area. J. Pediatr. Endocrinol. Metab. 19(3), 205-208 (2006).
36. Holick M: High prevalence of vitamin D inadequacy and implications for health. Mayo Clin. Proc. 81, 353-1337 (2006).
37. Kreiter SR, Schwartz R P, Kirkman HN Jr, Charlton PA, Calikoglu AS, Davenport ML: Nutritional rickets in African-American breast-fed infants. J. Pediatr. 137(2), 153-157 (2000).
38. Mylott BM, Kump T, Bolton ML, Greenbaum LA: Rickets in the dairy state. WMJ. 103(5), 84-87 (2004).
39. Weisberg P, Scanlon KS, Li R, Cogswell ME: Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003. Am. J. Clin. Nutr. 80(6 Suppl), 1697S-1705S (2004).
40. Shah M, Salhab N, Patterson D, Seikaly MG: Nutritional rickets still affict children in north Texas. Tex. Med. 96(6), 64-68 (2000).
41. Stevens RL, Lyon C: Nutritional vitamin D defciency: a case report. Cases J. 2, 7000 (2009).
42. Wondale Y, Shiferaw F, Lulseged S: A systematic review of nutritional rickets in Ethiopia: status and prospects. Ethiop. Med. J. 43(3), 203-210 (2005).
43. Beck-Nielsen SS, Jensen TK, Gram J, Brixen K, Brock-Jacobsen B: Nutritional rickets in Denmark: a retrospective review of children's medical records from 1985 to 2005. Eur. J. Pediatr. 168(8), 941-949 (2009).
44. Robinson PD, Hogler W, Craig ME et al.: The re-emerging burden of rickets: a decade of experience from Sydney. Arch. Dis. Child. 91(7), 564-568 (2006).
45. Cramm KJ, Cattaneo RA, Schremmer RD: An infant with tachypnea. Pediatr. Emerg. Care. 22(11), 728-731 (2006).
46. Kosecik M, Ertas T: Dilated cardiomyopathy due to nutritional vitamin D defciency rickets. Pediatr. Int. 49(3), 397-399 (2007).
47. Schnadower D, Agarwal C, Oberfeld SE, Fennoy I, Pusic M: Hypocalcemic seizures and secondary bilateral femoral fractures in an adolescent with primary vitamin D defciency. Pediatrics 118(5), 2226-2230 (2006).
48. Nabulsi M, Mahfoud Z, Maalouf J, Arabi A, Fuleihan GE: Impact of maternal veiling during pregnancy and socioeconomic status on offspring's musculoskeletal health. Osteoporos. Int. 19(3), 295-302 (2008).
49. Soliman AT, Al Khalaf F, Alhemaidi N, Al Ali M, Al Zyoud M, Yakoot K: Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D defciency Metabolism 57(1), 95-102 (2008).
50. Mikati MA, Dib L, Yamout B, Sawaya R, Rahi AC, Fuleihan Gel H: Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology 67(11), 2005-2014 (2006).
51. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110(2), 229-238 (2002).
52. 2 3 renin-angiotensin system in 1a-hydroxylase knockout mice. Kidney Int. 74(2), 170-179 (2008).
53. Yuan W, Pan W, Kong J et al.: 1,25-dihydroxyvitamin D suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J. Biol. Chem. 282(41), 29821-29830 (2007).
54. Wong MS, Delansorne R, Man RY, Vanhoutte PM: Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am. J. Physiol. Heart Circ. Physiol. 295(1), H289-296 (2008).
55. Talmor Y, Bernheim J, Klein O, Green J, Rashid G: Calcitriol blunts pro-atherosclerotic parameters through NFkB and p38 in vitro. Eur. J. Clin. Invest. 38(8), 548-554 (2008).
56. Wang L, Manson JE, Buring JE, Lee IM, Sesso HD: Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 51(4), 1073-1079 (2008).
57. Peterlik M, Cross HS: Vitamin D and calcium defcits predispose for multiple chronic diseases. Eur. J. Clin. Invest. 35(5), 290-304 (2005).
58. Fitzpatrick LA, Bilezikian JP, Silverberg SJ: Parathyroid hormone and the cardiovascular system. Curr. Osteoporos. Rep. 6(2), 77-88 (2008).
59. Snijder MB, Lips P, Seidell JC et al.: Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J. Intern. Med. 261(6), 558-565 (2007).
60. Reis JP, von Muhlen D, Miller ER 3rd, Michos ED, Appel LJ: Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics (2009).
61. Mathieu C, Adorini L: The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mo l. Med. 8(4), 174-179 (2002).
62. 3-a hormone with immunomodulatory properties. Z. Rheumatol. 59(Suppl. 1), 24-27 (2000).
63. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R: Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 37(6), 552-558 (1994).
64. Giulietti A, Gysemans C, Stoffels K et al.: Vitamin D defciency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 47(3), 451-462 (2004).
65. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J: Incidence of childhood Type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23(10), 1516-1526 (2000).
66. Mohr SB, Garland CF, Gorham ED, Garland FC: The association between ultraviolet B irradiance, vitamin D status and incidence rates of Type 1 diabetes in 51 regions worldwide. Diabetologia 51(8), 1391-1398 (2008).
67. Littorin B, Blom P, Scholin A et al.: Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune Type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 49(12), 2847-2852 (2006).
68. Greer RM, Rogers MA, Bowling FG et al.: Australian children and adolescents with Type 1 diabetes have low vitamin D levels. Med. J. Aust. 187(1), 59-60 (2007).
69. Pozzilli P, Manfrini S, Crino A et al.: Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed Type 1 diabetes. Horm. Metab. Res. 37(11), 680-683 (2005).
70. Svoren BM, Volkening LK, Wood JR, Laffel LM: Signifcant vitamin D defciency in youth with Type 1 diabetes mellitus. J. Pediatr.154(1), 132-134 (2009).
71. Bener A, Alsaied A, Al-Ali M et al.: High prevalence of vitamin D defciency in Type 1 diabetes mellitus and healthy children. ACTA Diabetol. 46(3), 183-189 (2009).
72. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM: Intake of vitamin D and risk of Type 1 diabetes: a birth-cohort study. Lancet 358(9292), 1500-1503 (2001).
73. Stene LC, Joner G: Use of cod liver oil during the frst year of life is associated with lower risk of childhood-onset Type 1 diabetes: a large, population-based, case-control study. Am. J. Clin. Nutr. 78(6), 1128-1134 (2003).
74. Group TESS: Vitamin D supplement in early childhood and risk for Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 42, 51-54 (1999).
75. Tenconi MT, Devoti G, Comelli M et al.: Major childhood infectious diseases and other determinants associated with Type 1 diabetes: a case-control study. Acta Diabetol. 44(1), 14-19 (2007).
76. Stene LC, Ulriksen J, Magnus P, Joner G: Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 43(9), 1093-1098 (2000).
77. Zipitis CS, Akobeng AK: Vitamin D supplementation in early childhood and risk of Type 1 diabetes: a systematic review and meta-ana lysis. Arch. Dis. Child. 93(6), 512-517 (2008).
78. Dahlquist GG, Patterson C, Soltesz G: Perinatal risk factors for childhood Type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care. 22(10), 1698-1702 (1999).
79. Stene LC, Barriga K, Norris JM et al.: Perinatal factors and development of islet autoimmunity in early childhood: the diabetes autoimmunity study in the young. Am. J. Epidemiol. 160(1), 3-10 (2004).
80. Fronczak CM, Baron AE, Chase HP et al.: In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care 26(12), 3237-3242 (2003).
81. Siddiqui S CE, Zou M et al.: High dietary calcium and vitamin D effects on fat mass accretion and expression of liver enzymes in rats. FASEB J. 21(A), 56 (2007).
82. Endo I, Inoue D, Mitsui T et al.: Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144(12), 5138-5144 (2003).
83. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al.: Effect of Vitamin D on falls: a meta-ana lysis. JAMA 291(16), 1999-2006 (2004).
84. Arabi A, Baddoura R, Awada H, Salamoun M, Ayoub G, El-Hajj Fuleihan G: Hypovitaminosis D osteopathy: is it mediated through PTH, lean mass, or is it a direct effect? Bone 39(2), 268-275 (2006).
85. Sato Y, Iwamoto J, Kanoko T, Satoh K: Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc. Dis. 20(3), 187-192 (2005).
86. Teegarden D, White KM, Lyle RM et al.: Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring). 16(7), 1566-1572 (2008).
87. Caan B, Neuhouser M, Aragaki A et al.: Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch. Intern. Med. 167(9), 893-902 (2007).
88. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, Deluca HF: Cellular mechanisms of insulin release: the effects of vitamin D defciency and repletion on rat insulin secretion. Endocrinology 113(4), 1511-1518 (1983).
89. Ashraf A, Alvarez J, Saenz K, Gower B, McCormick K, Franklin F: Threshold for effects of vitamin D defciency on glucose metabolism in obese female African-American adolescents. J. Clin. Endocrinol. Metab. 94(9), 3200-3206 (2009).
90. Alemzadeh R, Kichler J, Babar G, Calhoun M: Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 57(2), 183-191 (2008).
91. Carbone LD, Rosenberg EW, Tolley EA et al.: 25-Hydroxyvitamin D, cholesterol, and ultraviolet irradiation. Metabolism 57(6), 741-748 (2008).
92. Auwerx J, Bouillon R, Kesteloot H: Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler. Thromb. 12(6), 671-674 (1992).
93. Liu P T, Stenger S, Li H et al.: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768), 1770-1773 (2006).
94. Walker V P, Modlin RL: The Vitamin D Connection to Pediatric Infections and Immune Function. Pediatr Res. 65(5 Pt 2), 106R-113R (2009).
95. McNally JD, Leis K, Matheson LA, Karuananyake C, Sankaran K, Rosenberg AM: Vitamin D defciency in young children with severe acute lower respiratory infection. Pediatr. Pulmonol. 44(10), 981-988 (2009).
96. Katikaneni R, Ponnapakkam T, Ponnapakkam A, Gensure R: Breastfeeding does not protect against urinary tract infection in the frst 3 months of life, but vitamin D supplementation increases the risk by 76%. Clin. Pediatr. 48(7), 750-755 (2009).
97. Linday LA, Shindledecker RD, Greer FR, Holick MF: Commentary on 'Breastfeeding Does Not Protect Against Urinary Tract Infection in the First 3 Months of Life, but Vitamin D Supplementation Increases the Risk by 76%'. Clin. Pediatr. 49(1), 93-94. (2009).
98. Erkkola M, Kaila M, Nwaru BI et al.: Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin. Exp. All. 39(6), 875-882 (2009).
99. Camargo CA Jr, Rifas-Shiman SL, Litonjua AA et al.: Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am. J. Clin. Nut. 85(3), 788-795 (2007).
100. Devereux G, Litonjua AA, Turner SW et al.: Maternal vitamin D intake during pregnancy and early childhood wheezing. Am. J. Clin. Nut. 85(3), 853-859 (2007).
101. Gale CR, Robinson SM, Harvey NC et al.: Maternal vitamin D status during pregnancy and child outcomes. Eur. J. Clin. Nut.62(1), 68-77 (2008).
102. Kulak CA, Borba VZ, Bilezikian JP, Silvado CE, Paola L, Boguszewski CL: Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq. Neuropsiquiatr. 62(4), 940-948 (2004).